SCHERING logo 228 (Fulvicin P G ultramicrocrystalline 125 mg)
Generic Name: griseofulvin
Pill imprint SCHERING logo 228 has been identified as Fulvicin P G ultramicrocrystalline 125 mg.
Fulvicin P/G is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea capitis; tinea barbae; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Fulvicin P/G ultramicrocrystalline 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- griseofulvin
- Imprint:
- SCHERING logo 228
- Strength:
- ultramicrocrystalline 125 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Schering-Plough Corporation
More about Fulvicin P/G (griseofulvin)
Consumer resources
- Other brands: Grifulvin V, Gris-PEG, Fulvicin U/F
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
